Imperative Care, a company with two FDA-cleared devices for stroke treatment, recently raised $160 million in a funding round led by D1 Capital Partners. It’s using the funds to build a portfolio of companies to treat stroke and vascular disease.
VivaLNK is currently developing a cardiac device, which is the centerpiece of a new platform with the capability to diagnose a-fibrillation more quickly and efficiently than traditional clinical standards.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.